
    
      -  In this research study, each cycle of study drug dosing will last 4 weeks (28 days).
           During each cycle, participants will take nilotinib by mouth twice daily. During the
           first cycle, participants will come to the clinic on Days 1 and 8. For Cycles 2-4 and
           every 3 cycles thereafter, they will come to the clinic on Day 1.

        -  The following tests and procedures will be performed at specific time points during
           study treatment: MRI or CT scans; physical examinations; vital signs; blood work;
           questionnaires and EKG.

        -  Participants may continue in this research study for as long as they do not have serious
           side effects or their disease does not get worse.
    
  